DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ERRIN
02 2NORETHINDRONE
01 176225
02 191209
03 1200980
01 3No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : ERRIN
Dosage Form : TABLET; ORAL-28
Application Number : 76225
Country : US
Patented : No
Drug : NORETHINDRONE
Dosage Form : TABLET; ORAL-28
Application Number : 91209
Country : US
Patented : No
Drug : NORETHINDRONE
Dosage Form : TABLET; ORAL-28
Application Number : 200980
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
